Atlas FDA

Predicate Research Report · generated 2026-08-22 · Print / save as PDF · Save to account

Biotest Medical Corp. · Predicate Candidate Screening

8 FDA 510(k) clearances under this manufacturer; the 50 most recent screened below.

151 daysmedian FDA review time
362 days90th percentile
8clearances measured
K-numberDeviceApplicantDecidedReview daysRecalls (K-match)
K141351SUPERCHECK PLUS BLOOD GLUCOSE MONITORING SYSTEM, SUPER CHECKBiotest Medical Corp.2015-05-193620
K133509EASY PLUS II BLOOD GLUCOSE MONITORING SYSTEM,EASY PLUS II MUBiotest Medical Corp.2014-02-21990
K123559SOLUSMOBILE BLOOD GLUCOSE MANAGMENT SYSTEMBiotest Medical Corp.2013-06-282210
K122525SMARTEST GLUCOWISE BLOOD GLUCOSE MONITORING SYSTEM, AND SMARBiotest Medical Corp.2013-05-022550
K100560EASY TALK BLOOD GLUCOSE MONITORING SYSTEM MODEL: 6277Biotest Medical Corp.2010-05-12720
K100701SMARTEST PERSONA BLOOD GLUCOSE TEST SYTEM MODEL: 6277Biotest Medical Corp.2010-04-08270
K093764SOLOV2 BLOOD GLUCOSE MONITORING SYSTEMBiotest Medical Corp.2010-03-02850
K091815SUPERCHECK 1 BLOOD GLUCOSE MONITORING SYSTEM, MODEL 6268Biotest Medical Corp.2009-11-161510

Methodology

Recall counts reflect FDA recall records explicitly referencing each K-number; FDA links recalls to K-numbers inconsistently, so 0 means "none found in FDA records," not "never recalled." Data: FDA openFDA, refreshed weekly. Verify decisions of consequence against the primary source. Full candidate set and CSV export: atlasbyauro.com.

Prepared with Atlas

Predicate research, review-time statistics and recall monitoring for 510(k) teams: atlasbyauro.com/fda